Daiwa Securities Group’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1K | Hold |
80
| – | – | ﹤0.01% | 1281 |
|
|
2025
Q1 | $1K | Buy |
+80
| New | +$1K | ﹤0.01% | 1247 |
|
|
2022
Q4 | – | Sell |
-37
| Closed | – | – | 1361 |
|
|
2022
Q3 | $0 | Hold |
37
| – | – | ﹤0.01% | 1374 |
|
|
2022
Q2 | $0 | Hold |
37
| – | – | ﹤0.01% | 1399 |
|
|
2022
Q1 | $1K | Hold |
37
| – | – | ﹤0.01% | 1325 |
|
|
2021
Q4 | $1K | Hold |
37
| – | – | ﹤0.01% | 1346 |
|
|
2021
Q3 | $1K | Hold |
37
| – | – | ﹤0.01% | 1274 |
|
|
2021
Q2 | $2K | Hold |
37
| – | – | ﹤0.01% | 1147 |
|
|
2021
Q1 | $1K | Hold |
37
| – | – | ﹤0.01% | 1216 |
|
|
2020
Q4 | $1K | Sell |
37
-44
| -54% | -$1.19K | ﹤0.01% | 1195 |
|
|
2020
Q3 | $2K | Hold |
81
| – | – | ﹤0.01% | 1133 |
|
|
2020
Q2 | $1K | Hold |
81
| – | – | ﹤0.01% | 1176 |
|
|
2020
Q1 | $1K | Hold |
81
| – | – | ﹤0.01% | 1185 |
|
|
2019
Q4 | $2K | Hold |
81
| – | – | ﹤0.01% | 1156 |
|
|
2019
Q3 | $2K | Hold |
81
| – | – | ﹤0.01% | 1122 |
|
|
2019
Q2 | $2K | Hold |
81
| – | – | ﹤0.01% | 1134 |
|
|
2019
Q1 | $2K | Hold |
81
| – | – | ﹤0.01% | 1124 |
|
|
2018
Q4 | $2K | Hold |
81
| – | – | ﹤0.01% | 1094 |
|
|
2018
Q3 | $3K | Hold |
81
| – | – | ﹤0.01% | 1095 |
|
|
2018
Q2 | $2K | Hold |
81
| – | – | ﹤0.01% | 1132 |
|
|
2018
Q1 | $3K | Buy |
+81
| New | +$3K | ﹤0.01% | 1096 |
|